Cargando…
Immune-related (IR)-pneumonitis during the COVID-19 pandemic: multidisciplinary recommendations for diagnosis and management
Immune-related (IR)-pneumonitis is a rare and potentially fatal toxicity of anti-PD(L)1 immunotherapy. Expert guidelines for the diagnosis and management of IR-pneumonitis include multidisciplinary input from medical oncology, pulmonary medicine, infectious disease, and radiology specialists. Severe...
Autores principales: | Naidoo, Jarushka, Reuss, Joshua E, Suresh, Karthik, Feller-Kopman, David, Forde, Patrick M, Mehta Steinke, Seema, Rock, Clare, Johnson, Douglas B, Nishino, Mizuki, Brahmer, Julie R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316105/ https://www.ncbi.nlm.nih.gov/pubmed/32554619 http://dx.doi.org/10.1136/jitc-2020-000984 |
Ejemplares similares
-
Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology
por: Naidoo, Jarushka, et al.
Publicado: (2023) -
Chronic immune checkpoint inhibitor pneumonitis
por: Naidoo, Jarushka, et al.
Publicado: (2020) -
Pretreatment Lung Function and Checkpoint Inhibitor Pneumonitis in NSCLC
por: Reuss, Joshua E., et al.
Publicado: (2021) -
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events
por: Brahmer, Julie R, et al.
Publicado: (2021) -
Management of granulomatous lobular mastitis: an international multidisciplinary consensus (2021 edition)
por: Yuan, Qian-Qian, et al.
Publicado: (2022)